Need a specific person's email?
Browse Concarlo Therapeutics's employee directory (about 12 employees) and reveal verified emails free.
Concarlo Therapeutics's most common email format is FirstLast@concarlo.com (ex. JohnDoe@concarlo.com), used for 81% of concarlo.com addresses. Concarlo Therapeutics uses 4 email patterns.
| Format | Example | Share of concarlo.com |
|---|---|---|
| FirstLast@concarlo.comMost common | JohnDoe@concarlo.com | |
| LastFirst@concarlo.com | DoeJohn@concarlo.com | |
| First.Last@concarlo.com | John.Doe@concarlo.com | |
| FirstL@concarlo.com | JohnD@concarlo.com |
Browse Concarlo Therapeutics's employee directory (about 12 employees) and reveal verified emails free.
Biotechnology ResearchNew York, United States11-50 Employees
Concarlo Therapeutics is a biotechnology research company headquartered in Brooklyn, New York, founded in 2016. It pursues precision oncology by diagnosing and treating cancer through targeting the cellular pathway linked to p27Kip1. The firm highlights its IpY concept as an inhibitor designed to overcome CDK2 resistance, target p27, and inhibit both CDK4 and CDK2. In 2022, Concarlo announced leadership appointments, naming Vadim Shepel as Chief Business & Operating Officer and Dr. Allamneni as Chief Development Officer, signaling ongoing development of its pipeline from discovery through clinical stages. Operatively, the company sits within the biotechnology research sector with a focus on innovative approaches to drug resistance via the p27Kip1 pathway.
Most common format
FirstLast@concarlo.com
Example: JohnDoe@concarlo.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.